Abstract
Objective: The following animal studies have been conducted to investigate whether recombinant human lactoferrin (rh-LF) has the same effect as bovine lactoferrin (b-LF) in the prevention of preterm delivery.
Study Design: Female C3H/HeNCrj mice were pair-mated with male Crj:B6D2F1 mice. On day 15 of gestation, as a model of preterm delivery, a 50 μg/kg intraperitoneal injection of lipopolysaccharide (LPS) was administered twice with a 3-h interval between injections (2:00 and 5:00 PM). One hour prior to each LPS injection (1:00 and 4:00 PM), an intraperitoneal injection of saline, b-LF, or rh-LF (1 mg/body) was administered. In non-LPS-treated controls, an intraperitoneal injection of saline was administered 4 times (1:00, 2:00, 4:00 and 5:00 PM). Body weights and delivery times were recorded. To compare plasma levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) between experimental and other pregnant mice, prepared as above, were sacrificed 6 h after the second LPS injection, and then blood samples were obtained and analyzed.
Results: Preterm delivery occurred (16.2±0.4 days of gestation) in all LPS-treated mice that were not administered LF. LF significantly prolonged gestation of LPS-treated mice: b-LF+LPS, 17.8±0.3 days; rh-LF+LPS, 18.0±0.8 days (P<0.05). LF (1 mg/body) significantly suppressed plasma IL-6 in LPS-treated mice:b-LF+LPS, 1060±154; rh-LF+ LPSF, 244±59; LPS without LF, 1628±115 pg/mL (P<0.05). As well, LF (1 mg/body) significantly suppressed plasma TNF-α in LPS-treated mice: b-LF+LPS, 88±36; rh-LF+LPS, 37±30; LPS without LF, 114±49 pg/mL (P<0.05).
Conclusions: Rh-LF may prolong gestation in LPS-induced preterm delivery in mice, by suppressing LPS-induced plasma IL-6 and TNF-α augmentation.
References
1 Romero R, M Mazor, YK Wu, M Sirtori, E Oyarzun, MD Mitchell et al.: Infection in the pathogenesis of preterm labor. Semin Perinatol12 (1988) 262Search in Google Scholar
2 Drife J: Infection and preterm birth. Br J Obstet Gynaecol96 (1989) 112810.1111/j.1471-0528.1989.tb03186.xSearch in Google Scholar PubMed
3 Niemela A, M Kulomaa, P Vija, P Tuohimaa, S Saarikoski: Lactoferrin in human amniotic fluid. Hum Reprod4 (1989) 99Search in Google Scholar
4 Otsuki K, A Yoda, K Hirose, Y Shimizu, H Saito, T Yanaihara: Salivary lactoferrin in neonates with chorioamnionitis. Showa Univ J Med Sci9 (1997) 39Search in Google Scholar
5 Birgens HS: The interaction of lactoferrin with human monocytes. Dan Med Bull38 (1991) 244Search in Google Scholar
6 Otsuki K, A Yoda, H Saito, Y Mitsuhashi, Y Toma, Y Shimizu et al.: Amniotic fluid lactoferrin in intrauterine infection. Placenta20 (2–3) (1999) 17510.1053/plac.1998.0368Search in Google Scholar PubMed
7 Mitsuhashi Y, K Otsuki, A Yoda, Y Shimizu, H Saito, T Yanaihara: Effect of lactoferrin on lipopolysaccharide (LPS) induced preterm delivery in mice. Acta Obstet Gynecol Scand79 (2000) 355Search in Google Scholar
8 Kaga N, Y Katsuki, M Obata, Y Shibutani: Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am J Obstet Gynecol174 (1996) 754Search in Google Scholar
9 Kaga N, Y Katsuki, Y Futamura, M Obata, Y Shibutani: Role of urinary trypsin inhibitor in the maintenance of pregnancy in mice. Obstet Gynecol88 (1996) 872Search in Google Scholar
10 Kaga N, Y Katsuki, S Kajikawa, Y Shibutani: Preventive effect of ritodrine hydrochloride and/or urinary trypsin inhibitor against lipopolysaccharide-induced preterm delivery in mice. Acta Obstet Gynecol Scand76 (1997) 811Search in Google Scholar
11 Arnold RR, M Brewer, JJ Gauthier: Bactericidal activityof human lactoferrin; sensitivity of a variety of microorganisms. Infect Immun28 (1980) 893Search in Google Scholar
12 Staut J, S Norrell, JP Harrington: Kinetic effect of human lactoferrin on growth of Eschericia coli O-111. Int J Biochem16 (1984) 1043Search in Google Scholar
13 Ellison III RT, TJ Giehl, FM Laforce: Damage of outer membrane of the enteric Gram-negative bacteria by lactoferrin and transferring. Infect Immun56 (1988) 2774Search in Google Scholar
14 Soukka T, J Tenovuo, M lenander-Lumikari: Fungicidal effect of human lactoferrin against Candida albicans. FEMS Microbiol Lett90 (1992) 223Search in Google Scholar
15 Naidu SS, U Svensson, AR Kishore, AS Naidu: Relationship between antibacterial activity and porin binding of lactoferrin in Eschericia coli and Salmonella typhimurium. Antimicrob Agents Chemother37 (1993) 240Search in Google Scholar
16 Håversen L, GB Ohlsson, M Hahn-Zoric, ÅL Hanson, I Mattsby-Baltzer: Lactoferrin down-regulates the LPS-induced production in monocytic cells via NF-κB. Clellular Immunology220 (2002) 83Search in Google Scholar
17 Elass E, M Masson, J Mazurier, D Legrand: Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun70(4) (2002) 1860Search in Google Scholar
18 Lima MF, F Kierszenbaum: Lactoferrin effects on phagocytic cell function increased uptake and killing of an intracellular parasite by murine macrophages and monocytes. J Immunol134 (1985) 4176Search in Google Scholar
19 Zimecki M, J Mazurier, M Machnicki. et al.: Immunostimulatory activity of lactotransferrin and maturation of CD4, CD8 murine thymocytes. Immunol Lett30 (1991) 119Search in Google Scholar
20 Shau H, A Kim, SH Golub: Modulation of natural killer and lymphokine-activated killer cell cytotoxity by lactoferrin. J Leuk Biol51 (1992) 343Search in Google Scholar
21 Crouch SPM, KJ Slater, J Fletcher: Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood80 (1992) 235Search in Google Scholar
22 Cohen MS, J Mao, GT Rasmussen, et al.: Interaction of lactoferrin and lipopolysaccharide. Effects on the antioxidant property of lactoferrin and the ability of lipopolysaccharide to prime human neutrophils for enhanced superoxide formation. J Infect Dis166 (1992) 1375Search in Google Scholar
23 Machnicki M, M Zimecki, T Zagulski: Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin-6 in vivo. Int J Exp Pathol74 (1993) 433Search in Google Scholar
24 Zhang GH, DM Mann, CM Tsai: Neutralization of endotoxin in vivo and in vivo by a human lactoferrin-derived peptide. Infect Immun67 (1999) 1353Search in Google Scholar
25 Miyazawa K, C Mantel, L Lu, et al.: Lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J Immunol146(2) (1991) 723Search in Google Scholar
©2005 by Walter de Gruyter Berlin New York
